Your browser doesn't support javascript.
loading
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
Sharmin, Sifat; Lefort, Mathilde; Andersen, Johanna Balslev; Leray, Emmanuelle; Horakova, Dana; Havrdova, Eva Kubala; Alroughani, Raed; Izquierdo, Guillermo; Ozakbas, Serkan; Patti, Francesco; Onofrj, Marco; Lugaresi, Alessandra; Terzi, Murat; Grammond, Pierre; Grand'Maison, Francois; Yamout, Bassem; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Boz, Cavit; Trojano, Maria; McCombe, Pamela; Slee, Mark; Lechner-Scott, Jeannette; Turkoglu, Recai; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Prevost, Julie; Maimone, Davide; Skibina, Olga; Buzzard, Katherine; Van der Walt, Anneke; Van Wijmeersch, Bart; Csepany, Tunde; Spitaleri, Daniele; Vucic, Steve; Casey, Romain; Debouverie, Marc; Edan, Gilles; Ciron, Jonathan; Ruet, Aurélie; De Sèze, Jérôme; Maillart, Elisabeth; Zephir, Hélène; Labauge, Pierre; Defer, Gilles; Lebrun-Frénay, Christine; Moreau, Thibault; Berger, Eric.
Affiliation
  • Sharmin S; CORe, Department of Medicine, University of Melbourne, L4 East, Grattan St, Melbourne, VIC, 3050, Australia.
  • Lefort M; Rennes University, EHESP, REPERES, EA, 7449, Rennes, France.
  • Andersen JB; Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes), Rennes, France.
  • Leray E; The Danish Multiple Sclerosis Registry, Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
  • Horakova D; Rennes University, EHESP, REPERES, EA, 7449, Rennes, France.
  • Havrdova EK; Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes), Rennes, France.
  • Alroughani R; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Izquierdo G; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Ozakbas S; Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
  • Patti F; Hospital Universitario Virgen Macarena, Seville, Spain.
  • Onofrj M; Dokuz Eylul University, Konak, Izmir, Turkey.
  • Lugaresi A; Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania, Italy.
  • Terzi M; Multiple Sclerosis Center, University of Catania, Catania, Italy.
  • Grammond P; Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, Chieti, Italy.
  • Grand'Maison F; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Yamout B; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italia.
  • Prat A; Medical Faculty, 19 Mayis University, Samsun, Turkey.
  • Girard M; CISSS Chaudière-Appalache, Levis, Canada.
  • Duquette P; Neuro Rive-Sud, Greenfield Park, Quebec, Canada.
  • Boz C; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
  • Trojano M; CHUM MS Center and Universite de Montreal, Montreal, Canada.
  • McCombe P; CHUM MS Center and Universite de Montreal, Montreal, Canada.
  • Slee M; CHUM MS Center and Universite de Montreal, Montreal, Canada.
  • Lechner-Scott J; KTU Medical Faculty Farabi Hospital, Trabzon, Turkey.
  • Turkoglu R; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
  • Sola P; University of Queensland, Brisbane, Australia.
  • Ferraro D; Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Granella F; College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Prevost J; School of Medicine and Public Health, University Newcastle, Newcastle, Australia.
  • Maimone D; Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, Australia.
  • Skibina O; Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Buzzard K; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Van der Walt A; Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Van Wijmeersch B; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Csepany T; Department of Emergency and General Medicine, Parma University Hospital, Parma, Italy.
  • Spitaleri D; CSSS Saint-Jérôme, Saint-Jerome, Canada.
  • Vucic S; Neurology Unit, Garibaldi Hospital, Catania, Italy.
  • Casey R; Department of Neuroscience, Monash University, Melbourne, Australia.
  • Debouverie M; Department of Neurology, The Alfred Hospital, Melbourne, Australia.
  • Edan G; Department of Neurology, The Alfred Hospital, Melbourne, Australia.
  • Ciron J; Central Clinical School, Monash University, Melbourne, Australia.
  • Ruet A; Department of Neurology, The Alfred Hospital, Melbourne, Australia.
  • De Sèze J; Central Clinical School, Monash University, Melbourne, Australia.
  • Maillart E; Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium.
  • Zephir H; Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Labauge P; Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.
  • Defer G; Neurophysiology Department, Westmead Hospital, Sydney, Australia.
  • Lebrun-Frénay C; Université de Lyon, Université, Claude Bernard Lyon 1, F-69000, Lyon, France.
  • Moreau T; Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, Lyon, France.
  • Berger E; Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, 69003, Lyon, France.
CNS Drugs ; 35(11): 1217-1232, 2021 11.
Article in En | MEDLINE | ID: mdl-34536228
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Registries / Multiple Sclerosis, Relapsing-Remitting / Internationality / Fingolimod Hydrochloride / Natalizumab / Immunologic Factors Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Australia Country of publication: Nueva Zelanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Registries / Multiple Sclerosis, Relapsing-Remitting / Internationality / Fingolimod Hydrochloride / Natalizumab / Immunologic Factors Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Australia Country of publication: Nueva Zelanda